| Literature DB >> 8843626 |
Abstract
A massive diphtheria epidemic in Eastern Europe has resulted in increased anxiety that this disease could spread to other countries. This fear is realistic because there is a gap in the diphtheria immunity in large segments of the adult population in many industrialized countries. Experience to date suggests that an immunity gap in adults coupled with the presence of large numbers of susceptible children and adolescents creates the potential for an extensive epidemic. To prevent epidemics, countries should consider the immunogenicity and duration of protection provided by diphtheria toxoid given to children in the primary series and as booster doses. This paper reviews general issues related to the formulation of diphtheria immunization strategies, especially the need for booster doses in adults and the rationale for use of lower-strength diphtheria toxoid for persons older than 6 years of age.Entities:
Mesh:
Substances:
Year: 1996 PMID: 8843626 DOI: 10.1016/0264-410x(96)00021-7
Source DB: PubMed Journal: Vaccine ISSN: 0264-410X Impact factor: 3.641